Logo image
The innate resistance of Trypanosoma copemani to human serum
Journal article   Open access   Peer reviewed

The innate resistance of Trypanosoma copemani to human serum

J.M. Austen, U. Ryan, W.G.F. Ditcham, J.A. Friend and S.A. Reid
Experimental Parasitology, Vol.153, pp.105-110
2015
pdf
innate_resistance.pdfDownloadView
Author’s Version Open Access
url
Link to Published Version *Subscription may be requiredView

Abstract

Trypanosoma copemani is known to be infective to a variety of Australian marsupials. Characterisation of this parasite revealed the presence of stercorarian-like life-cycle stages in culture, which are similar to T. rangeli and T. cruzi. The blood incubation infectivity test (BIIT) was adapted and used to determine if T. copemani, like T. cruzi and T. rangeli, has the potential to grow in the presence of human serum. To eliminate any effects of anticoagulants on the complement system and on human high density lipoprotein (HDL), only fresh whole human blood was used. Trypanosoma copemani was observed by microscopy in all human blood cultures from day 5 to day 19 post inoculation (PI). The mechanism for normal human serum (NHS) resistance in T. copemani is not known. The results of this study show that at least one native Australian trypanosome species may have the potential to be infective for humans.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

210 File views/ downloads
103 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.261 Parasitology - Trypanosoma & Leishmania
1.261.596 Trypanosoma Biology
Web Of Science research areas
Parasitology
ESI research areas
Microbiology
Logo image